Safeguard Scientifics President and CEO Steve Zarrilli to Keynote NYSE Governance Services’ Pre- and Post-IPO Board Forum

Business Wire

WAYNE, Pa.--(BUSINESS WIRE)--

Safeguard Scientifics, Inc. (SFE) today announced that its President and CEO, Stephen T. Zarrilli, will be the keynote speaker at the Pre- and Post-IPO Board Forum, hosted by NYSE Governance Services, Corporate Board Member, on Wednesday, December 11, 2013 at 11:50am PST in San Francisco, CA.

This Board Forum is targeting newly listed public companies, as well as companies planning to go public within the next 12 months, to help educate directors on core regulatory and governance requirements and guide them through the series of necessary governance decisions. In addition, the Board Forum will examine how corporate governance dictates success, providing participants an in-depth review of leading practices. A series of panels will debate popular governance myths and realities and provide tips on building the most effective board, dealing with shareholders and institutional investors, and creating a roadmap to success in their new environment.

FORUM DETAILS:

   
-- Title: Pre- and Post-IPO Board Forum
-- Hosts: NYSE Governance Services, Corporate Board Member
-- Date: December 11, 2013
-- Time: 8:00am – 4:00pm PST
-- Location: The offices of PwC, 3 Embarcadero Center, San Francisco, CA 94111
-- Registration:

http://bit.ly/17bC6Z6

 

“Having been entrepreneurs, board members, financiers, managers and operators ourselves, the Safeguard team has amassed extensive experience, cultivated a deep network, and built an efficient platform of resources which can be utilized by the companies in our portfolio to build strategies, ramp sales and position themselves for a successful exit,” said Mr. Zarrilli. “Over the course of my own 30 year career, I’ve personally served as CEO and CFO of both publicly traded and privately held technology companies and have had substantial board governance experience having served on the boards of four other publicly traded enterprises over the last 15 years. I’m looking forward to sharing my insights with attendees to help them and their companies navigate the pre- and post-IPO waters.”

KEYNOTE DETAILS:

   
-- Keynote: 11:50am – 12:30pm PST
-- Title: The Role of the Board in the IPO Process
-- Room: Yosemite Training Room
-- Fireside Chat:

Stephen T. Zarrilli, President and CEO, Safeguard Scientifics; and TK Kerstetter, Chairman, NYSE Governance Services, Corporate Board Member and Host, NYSE Governance Services’ This Week in the Boardroom

 

“I look forward to sitting down with Steve to further explore the challenges and opportunities that pre- and post-IPO companies face as they formulate the right board structure for effective governance and long-term growth,” said Mr. Kerstetter, who will be interviewing Mr. Zarrilli during the Fireside Chat. “Clearly, Steve is the right person to be speaking to our attendees. Having been on both sides of the table, Steve understands the operational and strategic challenges that entrepreneurs face. He understands what it takes to build a great company based on his deep domain expertise as an entrepreneur, board member and financier. Steve's public and private company experience will prove invaluable for our guests.”

About Safeguard Scientifics

Founded in 1953 and based in the Greater Philadelphia area, Safeguard Scientifics, Inc. (SFE) is celebrating 60 years of building market leaders and fostering innovation and entrepreneurship. Today, Safeguard provides growth capital and operational support to healthcare and technology companies in medtech, healthtech, specialty pharmaceuticals, financial technology, digital media, and Enterprise 3.0. For more information, please visit our website at www.safeguard.com.

Safeguard Press Resources

Blog: blog.safeguard.com
Twitter: @Safeguard
StockTwits: SFE
LinkedIn: Safeguard Scientifics
YouTube: SafeguardSFE
SlideShare: SafeguardScientifics

Forward-Looking Statements

Except for the historical information contained herein, statements in this release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, among others, the Company’s ability to make good decisions about the deployment of capital, the fact that our partner companies may vary from period to period, the Company’s substantial capital requirements and the absence of liquidity from our partner company holdings, the Company’s inability to obtain maximum value for our partner company holdings, market valuations in sectors in which our partner companies operate, the Company’s inability to control our partner companies, the need to manage assets to avoid registration under the Investment Company Act of 1940, risks associated with our partner companies, and other uncertainties described in the Company’s filings with the Securities and Exchange Commission. Many of these factors are beyond the Company’s ability to predict or control. As a result, past financial performance should not be relied on as an indication of future performance. The Company does not assume any obligation to update any forward-looking statements or other information in this press release.

Contact:
Safeguard Scientifics, Inc.
For Investor Relations
John E. Shave III, 610-975-4952
Vice President, Business Development and Corporate Communications
jshave(at)safeguard(dot)com
or
For Media Relations
Heather R. Hunter, 610-975-4923
Director, Marketing Communications
hhunter(at)safeguard(dot)com

Rates

View Comments (0)